ASPI vs IONS · rev $23.8M vs rev $514.0M
ASP Isotopes Inc. Common Stock (ASPI) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
ASP Isotopes Inc. Common Stock (ASPI) is a chemicals company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ASPI revenue for 2025-12-31 was $23.8M. Net income was -$159.8M. Revenue was up 475.5% from 2024-12-31 to 2025-12-31. ASPI currently screens at market cap $620.7M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ASPI currently screens at market cap $620.7M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ASPI and IONS stock pages for the full models.
Not investment advice.